Pharmaceutics 2013, 5(4), 621-633; doi:10.3390/pharmaceutics5040621
Article

Oral Liquid Formulation of Levothyroxine Is Stable in Breakfast Beverages and May Improve Thyroid Patient Compliance

1,* email, 2email, 2email and 2email
Received: 15 November 2013; in revised form: 29 November 2013 / Accepted: 4 December 2013 / Published: 13 December 2013
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Patients on treatment with levothyroxine (T4) are informed to take this drug in the morning, at least 30 min before having breakfast. A significant decrease of T4 absorption was reported, in fact, when T4 solid formulations are taken with food or coffee. According to preliminary clinical study reports, administration of T4 oral solution appears to be less sensitive to the effect of breakfast beverages on oral bioavailability. In the present study, stability of T4 oral solution added to breakfast beverages was investigated. A 1 mL ampoule of single-dose Tirosint® oral solution (IBSA Farmaceutici Italia, Lodi, Italy) was poured into defined volumes of milk, tea, coffee, and coffee with milk warmed at 50 °C, as well as in orange juice at room temperature. Samples were sequentially collected up to 20 min and analyzed by validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods. The results of the study demonstrated that T4 is stable in all beverages after 20 min incubation. Demonstration of T4 stability is a prerequisite for a thorough evaluation of the effect of breakfast beverages on the bioavailability of T4 given as oral solution and for a better understanding of the reasons underlying a decreased T4 bioavailability administered as solid formulations.
Keywords: levothyroxine; T4; liquid formulation; LC-MS/MS; stability; coffee; milk; tea; orange juice; bioavailability
PDF Full-text Download PDF Full-Text [273 KB, uploaded 13 December 2013 17:15 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Bernareggi, A.; Grata, E.; Pinorini, M.T.; Conti, A. Oral Liquid Formulation of Levothyroxine Is Stable in Breakfast Beverages and May Improve Thyroid Patient Compliance. Pharmaceutics 2013, 5, 621-633.

AMA Style

Bernareggi A, Grata E, Pinorini MT, Conti A. Oral Liquid Formulation of Levothyroxine Is Stable in Breakfast Beverages and May Improve Thyroid Patient Compliance. Pharmaceutics. 2013; 5(4):621-633.

Chicago/Turabian Style

Bernareggi, Alberto; Grata, Elia; Pinorini, Maria T.; Conti, Ario. 2013. "Oral Liquid Formulation of Levothyroxine Is Stable in Breakfast Beverages and May Improve Thyroid Patient Compliance." Pharmaceutics 5, no. 4: 621-633.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert